UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

Journal of thrombosis and haemostasis, 2005-05, Vol.3 (5), p.848-853

2005

Volltextzugriff (PDF)

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.622-631

2012

Volltextzugriff (PDF)

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

Journal of thrombosis and haemostasis, 2005-12, Vol.3 (12), p.2619-2626

2005

Volltextzugriff (PDF)

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

BJOG : an international journal of obstetrics and gynaecology, 2012-11, Vol.119 (12), p.1529-1537

2012

Volltextzugriff (PDF)

Diagnosis and treatment of acquired haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-05, Vol.16 (102), p.102-106

2010

Volltextzugriff (PDF)

Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

Thrombosis and haemostasis, 2001-10, Vol.86 (4), p.954-958

2001

Volltextzugriff (PDF)

High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.e50-e53

2013

Volltextzugriff (PDF)

Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

Journal of thrombosis and haemostasis, 2006-10, Vol.4 (10), p.2164-2169

2006

Volltextzugriff (PDF)

Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 Years

Annals of internal medicine, 1995-11, Vol.123 (9), p.656

Gruppo Italiano Studio Policitemia

1995

Volltextzugriff (PDF)

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

Haematologica (Roma), 2009-04, Vol.94 (4), p.566-575

2009

Volltextzugriff (PDF)

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications : a controlled double-blind, randomized, multicenter study

Intensive care medicine, 1998-04, Vol.24 (4), p.336-342

1998

Volltextzugriff (PDF)

von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL)

Journal of thrombosis and haemostasis, 2005-12, Vol.3 (12), p.2684-2688

2005

Volltextzugriff (PDF)

d-Dimer Testing to Determine the Duration of Anticoagulation Therapy

The New England journal of medicine, 2006-10, Vol.355 (17), p.1780-1789

2006

Volltextzugriff (PDF)

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

Journal of thrombosis and haemostasis, 2009-05, Vol.7 (5), p.780-786

2009

Volltextzugriff (PDF)

Critical bleeding in pregnancy: a novel therapeutic approach to bleeding

Minerva anestesiologica, 2006-06, Vol.72 (6), p.389

2006

Volltextzugriff (PDF)

Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi®) in the treatment of von Willebrand disease: a retrospective clinical study

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-11, Vol.8 (6), p.761-767

2002

Volltextzugriff (PDF)

False incoagulable PT–INR results in oral anticoagulant therapy

Thrombosis research, 2008-01, Vol.122 (1), p.137-139

2008

Volltextzugriff (PDF)

Successful treatment with 2‐chlorodeoxyadenosine of secondary lesions of the central nervous system in low‐grade lymphoid malignancies

American journal of hematology, 2002-08, Vol.70 (4), p.332-333

2002

Volltextzugriff (PDF)

The Continuous Infusion of Recombinant Activated Factor VIIa (rFVIIa) in Patients with Factor VIII Inhibitors Activates the Coagulation and Fibrinolytic Systems without Clinical Complications

Thrombosis research, 2000-07, Vol.99 (1), p.21-24

2000

Volltextzugriff (PDF)

Health-related quality of life and psychological well-being in elderly patients with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.345-352

2012

Volltextzugriff (PDF)

Clinical phenotypes and factor VII genotype in congenital factor VII deficiency

Thrombosis and haemostasis, 2005-03, Vol.93 (3), p.481-487

2005

Volltextzugriff (PDF)

Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-03, Vol.12 (2), p.154-162

2006

Volltextzugriff (PDF)

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype

Haematologica (Roma), 2008-05, Vol.93 (5), p.722-728

2008

Volltextzugriff (PDF)

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.714-721

2010

Volltextzugriff (PDF)

A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III

The Journal of biological chemistry, 1994-12, Vol.269 (52), p.33129-33134

1994

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(123)
Science & Technology
(123)
Life Sciences & Biomedicine
(121)
Male
(64)
Female
(57)
Middle Aged
(54)
Hematology
(53)
Adult
(52)
Aged
(43)
Biological And Medical Sciences
(39)
Medical Sciences
(39)
Oncology
(35)
Cardiovascular System & Cardiology
(22)
Hematologic And Hematopoietic Diseases
(22)
Peripheral Vascular Disease
(22)
Urology & Nephrology
(22)
Adolescent
(19)
Surgery
(17)
Aged, 80 And Over
(16)
Mortality
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

Diagnosis and treatment of acquired haemophilia

Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors

High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review

Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study

Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 Years

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications : a controlled double-blind, randomized, multicenter study

von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL)

d-Dimer Testing to Determine the Duration of Anticoagulation Therapy

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

Critical bleeding in pregnancy: a novel therapeutic approach to bleeding

Clinical efficacy of highly purified, doubly virus-inactivated factor VIII/von Willebrand factor concentrate (Fanhdi®) in the treatment of von Willebrand disease: a retrospective clinical study

False incoagulable PT–INR results in oral anticoagulant therapy

Successful treatment with 2‐chlorodeoxyadenosine of secondary lesions of the central nervous system in low‐grade lymphoid malignancies

The Continuous Infusion of Recombinant Activated Factor VIIa (rFVIIa) in Patients with Factor VIII Inhibitors Activates the Coagulation and Fibrinolytic Systems without Clinical Complications

Health-related quality of life and psychological well-being in elderly patients with haemophilia

Clinical phenotypes and factor VII genotype in congenital factor VII deficiency

Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype

Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX‐2)

A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III

Suchergebnisse filtern